Shares of Arcutis Biotherapeutics (NASDAQ:ARQT), a biopharmaceutical company specializing in immuno-dermatology, surged 10.8% on the day after the announcement of a joint stipulation to stay the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback